Evidence map›Paper›PMID 31220172›Full record

ArticlePloS one2019

Molecular characterization of measles viruses in China: Circulation dynamics of the endemic H1 genotype from 2011 to 2017.

Huiling Wang, Yan Zhang, Naiying Mao, Zhen Zhu, Aili Cui, Songtao Xu, Jinhua Song, Meng Chen, Xueqiang Fang, Chongshan Li and 9 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Surveillance and agnostic capture sequencing of samples from individuals with rash-associated illness in Mali indicates regional transmission of measles virus from West and Central Africa.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Progress Toward Measles Elimination - China, January 2013-June 2019.MMWR. Morbidity and mortality weekly report · 2019
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 1 country.

Huiling WangNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.
Yan ZhangNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.ORCID 0000-0001-7299-7215
Naiying MaoNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.
Zhen ZhuNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.
Aili CuiNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.
Songtao XuNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.
Jinhua SongNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.
Meng ChenBeijing Center for Disease Control and Prevention, Beijing, People's Republic of China.
Xueqiang FangShandong Center for Disease Control and Prevention, Jinan, Shandong, People's Republic of China.
Chongshan LiShanghai Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Daxing FengHenan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.
Shujie ZhouAnhui Center for Disease Control and Prevention, Hefei, Anhui, People's Republic of China.
Shulei WangYantai Center for Disease Control and Prevention, Yantai, Shandong, People's Republic of China.
Jing ShiYizhuang Hosptial, Beijing, People's Republic of China.
Yixin JiNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.
Lei CaoNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.
Li RenNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.
Lingyu GaoNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.
Wenbo XuNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), WHO WPRO Regional Reference Laboratory of Measles/Rubella, Beijing, People's Republic of China.ORCID 0000-0002-5558-3018
National Institute for Viral Disease Control and Prevention · CNAnhui Provincial Center for Disease Control and Prevention · CNBeijing Center for Disease Prevention and Control · CNHenan Provincial Center for Disease Control and Prevention · CNShandong Center for Disease Control and Prevention · CNShanghai Municipal Center For Disease Control Prevention · CNYantai University · CNYuxian People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the Expanded Program on Immunization (EPI) and supplementary immunization activities (SIAs) in China, the incidence of measles in China has decreased extensively. The incidence reached its lowest levels in contemporary history in 2012 and 2017, with incidence rates of 4.6 and 4.3 per million population, respectively. However, more than 147,000 measles cases were reported from 2013 to 2016. Furthermore, the proportions of cases in infants < 8 months and adults have been increasing since 2013, representing a considerable challenge for measles elimination in China. A total of 14,868 measles viruses were isolated from confirmed measles cases from 2011 to 2017, of which 14,631 were identified as the predominant endemic genotype, H1; 87 were identified as genotype A viruses that were vaccine associated strains; and 150 were identified as non-H1 genotype viruses. The non-H1 genotype viruses included 62 D8 viruses, 70 D9 viruses, 3 D11 viruses, 14 B3 viruses, and 1 G3 virus, which were identified as imported or import-related viruses that caused sporadic cases or small outbreaks. Most of the transmission chains detected during the period 2011-2012 were interrupted and were followed by many new transmission chains of unknown origin that spread, causing a large measles resurgence in China during 2013-2016. After 4 years of measles resurgence and continuous implementation of the routine immunization program and SIAs, the population immunity reached a sufficiently high level to interrupt most of the transmission chains; only a few strains survived, which continued to be sporadically detected in China in 2017. In the present study, the results from the combined epidemiological and molecular virological data demonstrated the great progress towards measles elimination in China by the further analysis of circulation dynamics for the endemic H1 genotype measles virus from 2011 to 2017. And this study accumulated critical baseline data on circulating wild-type measles viruses in China and provides comprehensive information to the world. These comprehensive baseline data provide evidence to support measles elimination in the future, not only in China but also in other countries worldwide. In addition, the information will be very useful to other countries for tracing their sources of measles cases and for identifying transmission links, which can help prevent potential measles outbreaks.

Indexed as

AdolescentAdultChildChild, PreschoolChinaDisease OutbreaksEndemic DiseasesFemaleGenotypeHumansIncidenceInfantInfant, NewbornMaleMeaslesMeasles virus

Identifiers

PMID31220172
PMCPMC6586441
OpenAlexW2952315874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.